February 23, 2015
Polypore to be sold for $3.2 billion in two-step deal
Polypore International (NYSE:PPO) has agreed to be sold in a two-part, all-cash deal valued at $3.2 billion.
The deal involves the sale of Polypore’s two divisions to two separate companies. But the $1 billion in proceeds from the sale of its medical and chemical filtration business will go to the Japanese company that is paying the $3.2 billion price.
The Charlotte-based company’s battery separator business — including its Celgard subsidiary, which has major manufacturing operations in Charlotte…